$NMTC bottom secured, looking to break $1.20 for a bullish runNASDAQ:NMTC bottom secured, looking to break $1.20 for a bullish run. 20 DMA sitting at $1.20. Nice reversal possibilities when that falls.
Next report date
Report period
Q2 2024
EPS estimate
−0.10USD
Revenue estimate
1.47 MUSD
−0.68USD
−11.86 MUSD
3.41 MUSD
22.04 M
About NeuroOne Medical Technologies Corporation
Sector
Industry
CEO
David A. Rosa
Website
Headquarters
Eden Prairie
Employees (FY)
16
Founded
2009
FIGI
BBG001K7WBS9
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NMTC is 1.16 USD — it has increased by 1.75% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NeuroOne Medical Technologies Corporation stocks are traded under the ticker NMTC.
NeuroOne Medical Technologies Corporation is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
NMTC stock is 5.31% volatile and has beta coefficient of 0.76. Check out the list of the most volatile stocks — is NeuroOne Medical Technologies Corporation there?
NMTC earnings for the last quarter are −0.17 USD per share, whereas the estimation was −0.18 USD resulting in a 2.25% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about NeuroOne Medical Technologies Corporation earnings.
NeuroOne Medical Technologies Corporation revenue for the last quarter amounts to 742.00 K USD despite the estimated figure of 800.00 K USD. In the next quarter revenue is expected to reach 850.00 K USD.
Yes, you can track NeuroOne Medical Technologies Corporation financials in yearly and quarterly reports right on TradingView.
NMTC stock has risen by 1.75% compared to the previous week, the month change is a 9.38% fall, over the last year NeuroOne Medical Technologies Corporation has showed a 29.70% decrease.
NMTC net income for the last quarter is −3.34 M USD, while the quarter before that showed −3.14 M USD of net income which accounts for −6.69% change. Track more NeuroOne Medical Technologies Corporation financial stats to get the full picture.
Today NeuroOne Medical Technologies Corporation has the market capitalization of 30.08 M, it has decreased by 0.87% over the last week.
No, NMTC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NMTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NeuroOne Medical Technologies Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 16.00 employees. See our rating of the largest employees — is NeuroOne Medical Technologies Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NeuroOne Medical Technologies Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NeuroOne Medical Technologies Corporation stock shows the sell signal. See more of NeuroOne Medical Technologies Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NeuroOne Medical Technologies Corporation future price: according to them, NMTC price has a max estimate of 3.15 USD and a min estimate of 2.00 USD. Read a more detailed NeuroOne Medical Technologies Corporation forecast: see what analysts think of NeuroOne Medical Technologies Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NeuroOne Medical Technologies Corporation EBITDA is −13.34 M USD, and current EBITDA margin is −344.99%. See more stats in NeuroOne Medical Technologies Corporation financial statements.